Please login to the form below

PME supplements

PMEA Awards 2014 Digital Publication

See which healthcare communications programmes made a real difference to health outcomes with the Communiqué Awards digital publication.

The Heart of the Matter 4 - Innovation: it's a risky business

There is no such thing as a magic formula for innovation. But as some of modern business’s biggest visionaries will attest, the killer ingredient is often ‘risk’

10 ways to meet event disclosure rules

Ashfield Meetings & Events provide a practice guide to the forthcoming European changes

The Heart of the Matter 3 - Is pharma doing enough to maximise real world evidence?

McCann Complete Medical - Is pharma doing enough to maximise real world evidence?

RWE is currently de rigueur across pharma, and understandably so; getting it right may determine how brands perform in an evolving healthcare environment

The Heart of the Matter 2 - How is social media impacting publication planning?

The rise in digital communications, turbo-charged of late by social media, has wrought huge changes in the way health information is consumed, discussed and shared.

Communiqué Awards 2014 Digital Publication

See which healthcare communications programmes made a real difference to health outcomes with the Communiqué Awards digital publication.

The Heart of the Matter 1 - Closing the Clinical Care Gap

The application of evidence-based medicine, the role of behavioural science and the power of real world evidence, in association with McCann Complete Medical

10 Ways to drive sales force effectiveness

How to empower your account teams to meet the challenges of a changing marketplace

Innovating Outsourcing

2014 promises to be another exciting year for pharma and Ashfield

2013 Pharmaceutical Market Excellence Awards

See the 2013 PMEA Winners and Finalists.

Strategic communications for orphan drugs

The fourth in our series of supplements on orphan drugs and rare diseases, this last issue for 2013 covers the place of strategic communications.

The Adherence Construct

How to build patient support programmes that last the course, in association with RAPP

Orphan drugs and rare diseases – value demonstration

The third in a series of supplements to look at orphan drugs and rare disease, this issue covers the role of value demonstration.

Early access and regulation

The second in a series of supplements to look at orphan drugs and rare disease, this issue covers early access and regulation.

Communiqué Awards digital publication

See which healthcare communications programmes made a real difference to health outcomes with the Communiqué Awards digital publication.

10 Ways to maximise your PMHub profile

Any journalist or communications expert worth his salt will tell you that content is king and this practical guide by PMGroup explains how to make the most of it to maximise the effectiveness of a PMHub profile.

Orphan drugs and rare diseases

The first in a series of supplements to look at orphan drugs and rare disease, this issue covers contract research organisations (CROs) and trial design.

How to work with global online doctor networks

Most senior pharma executives recognise that pharma lags behind many other industries in using digital tactics for effective sales and marketing. In fact, statistics show that, globally, the pharma industry spends only 15.3 per cent of its marketing budgets on digital (Across Health 2013), and most of this continues to be devoted to brand.com websites.